A Saccharomyces boulardii synthetic biotic platform for delivery of therapeutic nanobodies to ameliorate gastrointestinal inflammation
Roger Palou, Almer M. van der Sloot, Aline Fiebig‐Comyn, Megan T. Zangara, Naseer Sangwan, María Sánchez‐Osuna, Bushra Ilyas, Haley L. Zubyk, Michael A. Cook, Gerard D. Wright, Brian K. Coombes, Mike Tyers
This paper develops a Saccharomyces boulardii platform for producing and delivering therapeutic nanobodies to treat gastrointestinal inflammation in mice.
bioRxiv · May 15, 2025 · PreprintSynthetic Biology